<DOC>
	<DOCNO>NCT01424410</DOCNO>
	<brief_summary>Objective Hypotheses : This project overall objective implement evaluate new approach reduce current future burden urinary schistosomiasis young child use antihelminthic drug praziquantel . The investigator hypothesis ( 1 ) praziquantel treatment effective child 1 5 year age ( routinely exclude schistosomiasis control program ) old 6-10 year old child ( 2 ) two treatment effective single treatment , especially child 1 5 year age .</brief_summary>
	<brief_title>Health Benefits Repeated Treatment Pediatric Schistosomiasis</brief_title>
	<detailed_description>This study aim address present health inequity refinement exist drug regimen improve current future health pre-school child infant . Praziquantel cheap , highly efficacious safe , present realistic opportunity use pre-existing tool modify way benefit child health development . The study focus child age 1 10 year age , compare impact single vs. double treatment PZQ current future health status child . The immediate health benefit PZQ treatment child age 6-10 year age already document therefore include 6-10 year old propose study , determine effect PZQ treatment health morbidity measure age dependent . By kill worm PZQ stop morbidity relate presence worm egg anaemia , abdominal pain , diarrhoea blood urine . Therefore study investigate immediate health benefit treat pre-school child infant .</detailed_description>
	<mesh_term>Schistosomiasis</mesh_term>
	<criteria>1. lifelong resident area 2. provide least 2 urine 2 stool parasitological examination 3. give blood sample treatment episode 4. negative hookworm , Trichuris Ascaris 1. clinical sign tuberculosis malaria 2. present fever 3. recent major operation , illness vaccination 4. previously receive antihelminthic treatment</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>paediatric schistosomiasis morbidity immunology</keyword>
</DOC>